Caleigh Mandel-Brehm, PhD
Assistant ProfessorCards
About
Research
Publications
2025
327 Characterizing antigen specificities of skin-infiltrating B and plasma cells in cutaneous lupus reveals anti-nuclear and hemidesmosome-specific targets
Little A, Workineh A, Jiang R, Sky M, Kuragu A, Lin J, Kleinstein S, Mandel-Brehm C, O'Connor K, Craft J. 327 Characterizing antigen specificities of skin-infiltrating B and plasma cells in cutaneous lupus reveals anti-nuclear and hemidesmosome-specific targets. Journal Of Investigative Dermatology 2025, 145: e83. DOI: 10.1016/j.jid.2025.09.329.Peer-Reviewed Original ResearchLB1038 Characterizing antigen specificities of skin-infiltrating B and plasma cells in cutaneous lupus reveals anti-nuclear and hemidesmosome-specific targets
Little A, Workineh A, Sky M, Jiang R, Kuragu A, Suresh A, Kleinstein S, Mandel-Brehm C, O'Connor K, Craft J. LB1038 Characterizing antigen specificities of skin-infiltrating B and plasma cells in cutaneous lupus reveals anti-nuclear and hemidesmosome-specific targets. Journal Of Investigative Dermatology 2025, 145: s180. DOI: 10.1016/j.jid.2025.06.1570.Peer-Reviewed Original ResearchEpitope Mapping and Autoantigen Profiling in Hu-Associated Paraneoplastic Neurological Syndromes Using PhIP-Seq (S18.004)
Villagran-Garcia M, Wucher V, Mandel-Brehm C, Farina A, Pluvinage J, Cadet L, Pinto A, Muniz-Castrillo S, Abichou-Klich A, Picard G, Rogemond V, Wilson M, DeRisi J, Honnorat J. Epitope Mapping and Autoantigen Profiling in Hu-Associated Paraneoplastic Neurological Syndromes Using PhIP-Seq (S18.004). Neurology 2025, 104 DOI: 10.1212/wnl.0000000000211782.Peer-Reviewed Original Research
2024
Granulomatous Inflammation on Neuropathology in Antibody-associated CNS Paraneoplastic Syndromes
Gelfand J, Gerdts J, Mandel-Brehm C, Guo Y, DeRisi J, Meyronet D, Desestret V, Pleasure S, Wilson M, Dubey D, Honnorat J. Granulomatous Inflammation on Neuropathology in Antibody-associated CNS Paraneoplastic Syndromes. Neurology 2024, 103 DOI: 10.1212/01.wnl.0001051580.73402.bd.Peer-Reviewed Original ResearchMolecular mimicry in multisystem inflammatory syndrome in children
Bodansky A, Mettelman R, Sabatino J, Vazquez S, Chou J, Novak T, Moffitt K, Miller H, Kung A, Rackaityte E, Zamecnik C, Rajan J, Kortbawi H, Mandel-Brehm C, Mitchell A, Wang C, Saxena A, Zorn K, Yu D, Pogorelyy M, Awad W, Kirk A, Asaki J, Pluvinage J, Wilson M, Zambrano L, Campbell A, Thomas P, Randolph A, Anderson M, DeRisi J. Molecular mimicry in multisystem inflammatory syndrome in children. Nature 2024, 632: 622-629. PMID: 39112696, PMCID: PMC11324515, DOI: 10.1038/s41586-024-07722-4.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 nucleocapsid proteinInflammatory syndromeMultisystem inflammatory syndromePost-infectious sequelaeMIS-CNucleocapsid proteinSARS-CoV-2 proteomeSARS-CoV-2Nucleocapsid protein epitopesCross-reactive T cellsMIS-C pathogenesisAssociated with cross-reactivityHost proteinsSNX8Viral nucleocapsidT cellsAutoinflammatory diseasesPathophysiological mechanismsPatient autoantibodiesProteinImmune responseAntibody responseProtein epitopesMolecular mimicryPatientsUnveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR-T therapies in autoimmunity
Bodansky A, Yu D, Rallistan A, Kalaycioglu M, Boonyaratanakornkit J, Green D, Gauthier J, Turtle C, Zorn K, O'Donovan B, Mandel-Brehm C, Asaki J, Kortbawi H, Kung A, Rackaityte E, Wang C, Saxena A, de Dios K, Masi G, Nowak R, O'Connor K, Li H, Diaz V, Saloner R, Casaletto K, Gontrum E, Chan B, Kramer J, Wilson M, Utz P, Hill J, Jackson S, Anderson M, DeRisi J. Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR-T therapies in autoimmunity. Journal Of Clinical Investigation 2024, 134: e180012. PMID: 38753445, PMCID: PMC11213466, DOI: 10.1172/jci180012.Peer-Reviewed Original ResearchB-cell maturation antigenImmunomodulatory therapyPlasma cell-targeted therapyCAR-T therapyCell-targeted therapyAutoantibody mediated diseasesCAR-TAnti-CD19Maturation antigenAutoantibody profileAutoreactive antibodiesTargeted therapyPlasma cellsAutoimmune diseasesAutoantibody repertoireTherapyMediated diseasesAutoantibodiesTherapeutic interventionsProteome-wideDisease statesDiseaseImmunological fingerprintPhIP-SeqMinimal effect38. Identifying Novel Molecular Drivers of Autoimmunity in Paraneoplastic Anti-NMDAR Encephalitis
Gardin T, DiStasio M, Mandel-Brehm C, Bhatta S, Hafler D. 38. Identifying Novel Molecular Drivers of Autoimmunity in Paraneoplastic Anti-NMDAR Encephalitis. Biological Psychiatry 2024, 95: s90-s91. DOI: 10.1016/j.biopsych.2024.02.216.Peer-Reviewed Original Research
2023
Validation of a murine proteome-wide phage display library for identification of autoantibody specificities
Rackaityte E, Proekt I, Miller H, Ramesh A, Brooks J, Kung A, Mandel-Brehm C, Yu D, Zamecnik C, Bair R, Vazquez S, Sunshine S, Abram C, Lowell C, Rizzuto G, Wilson M, Zikherman J, Anderson M, DeRisi J. Validation of a murine proteome-wide phage display library for identification of autoantibody specificities. JCI Insight 2023, 8: e174976. PMID: 37934865, PMCID: PMC10795829, DOI: 10.1172/jci.insight.174976.Peer-Reviewed Original ResearchConceptsPhIP-SeqPolygenic modelAutoimmune polyendocrinopathy syndrome type 1Phage display libraryMouse modelLupus-like diseaseAutoimmune disease modelsRecessive mutationsDisplay libraryTissue-specificPeptide enrichmentAutoimmune profileMouse autoantibodiesImmune perturbationsAutoantibody discoveryAutoantibody specificitiesSystem antigensMouse linesMouse seraType 1Antigenic profileMiceAntibody productionPancreatic proteinCross-reactivity
2022
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq
Vazquez S, Mann S, Bodansky A, Kung A, Quandt Z, Ferré E, Landegren N, Eriksson D, Bastard P, Zhang S, Liu J, Mitchell A, Proekt I, Yu D, Mandel-Brehm C, Wang C, Miao B, Sowa G, Zorn K, Chan A, Tagi V, Shimizu C, Tremoulet A, Lynch K, Wilson M, Kämpe O, Dobbs K, Delmonte O, Bacchetta R, Notarangelo L, Burns J, Casanova J, Lionakis M, Torgerson T, Anderson M, DeRisi J. Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq. ELife 2022, 11: e78550. PMID: 36300623, PMCID: PMC9711525, DOI: 10.7554/elife.78550.Peer-Reviewed Original ResearchConceptsPhIP-SeqRAG1/2 deficiencyAutoantibody discoveryPhage immunoprecipitation sequencingPrediction of disease statusImmunoprecipitation sequencingDisease-specific autoantigensKawasaki diseaseMIS-CAPS1RAG1/2APS1 patientsMultisystem inflammatory syndromeBEST4Robust predictionsSevere COVID-19Cohort of casesEEA1PhageInflammatory syndromeIPEX patientsImmune dysregulationAutoantigensDiscoveryAutoimmune diseasesAutoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
Mandel-Brehm C, Vazquez S, Liverman C, Cheng M, Quandt Z, Kung A, Parent A, Miao B, Disse E, Cugnet-Anceau C, Dalle S, Orlova E, Frolova E, Alba D, Michels A, Oftedal B, Lionakis M, Husebye E, Agarwal A, Li X, Zhu C, Li Q, Oral E, Brown R, Anderson M, Garg A, DeRisi J. Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy. Diabetes 2022, 72: 59-70. PMID: 35709010, PMCID: PMC9797316, DOI: 10.2337/db21-1172.Peer-Reviewed Original ResearchConceptsAutoimmune polyendocrine syndrome type 1Immune toleranceAcquired lipodystrophyIdiopathic subtypeMurine modelProteins perilipin 1Immune-related adverse eventsAcquired Generalized LipodystrophyImmune-mediated pathologyFeatures of autoimmunitySubtypes of lipodystrophyRadioligand binding assaysCancer immunotherapyGeneralized lipodystrophyPerilipin 1Proteome-wide screening approachAdverse eventsControl subjectsAutoantibodiesLipodystrophyType 1Indirect immunofluorescenceFat tissuePatientsBinding assays
Clinical Trials
Current Trials
Neurologic Autoimmune Disease Research Study
HIC ID2000039436RoleSub InvestigatorPrimary Completion Date12/31/2026Recruiting Participants
Academic Achievements & Community Involvement
News & Links
Get In Touch
Contacts
Administrative Support
Locations
LH315B
Lab
Brady Memorial Laboratory
310 Cedar Street, Fl 3, Rm 363
New Haven, CT 06510